www.washingtonexaminer.com
Antibody injection dramatically reduces risk of coronavirus illness, Regeneron says | Washington Examiner
Regeneron Pharmaceuticals will request federal approval to use its antibody treatment as a preventative measure after researchers found it significantly reduced the risk that healthy trial volunteers exposed to COVID-19 would develop the disease.
